These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30008076)

  • 21. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections.
    Metan G; Alp E; Yildiz O; Percin D; Aygen B; Sumerkan B
    J Chemother; 2010 Apr; 22(2):110-4. PubMed ID: 20435570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tigecycline therapy in pediatric patients with multidrug resistant bacteremia.
    Ozkaya-Parlakay A; Gulhan B; Kanik-Yuksek S; Guney D; Gonulal D; Demirtas G; Tezer H; Unal S; Senel E
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Dec; 38(10):471-473. PubMed ID: 32081452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacodynamic simulation to evaluate tigecycline in treatment of nosocomial pneumonia caused by multidrug-resistant Acinetobacter baumannii.
    Ni WT; Liang BB; Cai Y; Liu YP; Bai N; Cui JC; Wang R
    Pak J Pharm Sci; 2014 May; 27(3):463-7. PubMed ID: 24811802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.
    Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W
    Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline.
    Gordon NC; Wareham DW
    J Antimicrob Chemother; 2009 Apr; 63(4):775-80. PubMed ID: 19158109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EVALUATION OF IN VITRO TIGECYCLINE ACTIVITY AGAINST MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII CLINICAL ISOLATES FROM POLAND.
    Paluchowska P; Nowak P; Skalkowska M; Bjdak A
    Acta Pol Pharm; 2017 May; 74(3):793-800. PubMed ID: 29513948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M; Ehlers MM; Dreyer AW; Kock MM
    BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran.
    Sarhaddi N; Soleimanpour S; Farsiani H; Mosavat A; Dolatabadi S; Salimizand H; Amel Jamehdar S
    J Glob Antimicrob Resist; 2017 Mar; 8():60-66. PubMed ID: 28011349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Tigecycline to Treat Multidrug-resistant Infections in Pediatrics: An Evidence Synthesis.
    Sharland M; Rodvold KA; Tucker HR; Baillon-Plot N; Tawadrous M; Hickman MA; Raber S; Korth-Bradley JM; Díaz-Ponce H; Wible M
    Pediatr Infect Dis J; 2019 Jul; 38(7):710-715. PubMed ID: 31192975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
    Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
    Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M; Righi E; Esposito S; Petrosillo N; Nicolini L
    Future Microbiol; 2008 Dec; 3(6):649-60. PubMed ID: 19072182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S; Tribuddharat C; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights.
    Ibrahim MM; Abuelmatty AM; Mohamed GH; Nasr MA; Hussein AK; Ebaed MED; Sarhan HA
    Drug Des Devel Ther; 2018; 12():4171-4179. PubMed ID: 30584281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Activity of Various Antibiotics in Combination with Tigecycline Against Acinetobacter baumannii: A Systematic Review and Meta-Analysis.
    Li J; Yang X; Chen L; Duan X; Jiang Z
    Microb Drug Resist; 2017 Dec; 23(8):982-993. PubMed ID: 28437233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.